Global Custom Antibody Market is valued approximately USD 355.33 million in 2020 and is anticipated to grow with a healthy growth rate of more than 10.6% over the forecast period 2021-2027.
The growing number of research and development activities, the quality concerns over catalog antibodies, coupled with increasing industry-academia collaborations are the primary factors that are accelerating the market growth across the globe. For instance, in 2021, SunRock Biopharma and GenScript entered into a partnership agreement with the aim of developing therapeutic antibody candidates. GenScript will present solutions to SunRock Biopharma for the discovery of antibodies, process development for GMP drug substances, cell line development, and drug product manufacturing services. Similarly, in 2021, Abingdon Health (UK) and Abcam plc were involved in a co-marketing and collaboration agreement to reinforce Abcam's customer base. Furthermore, increasing availability of funds in life science research by the government organizations, along with a rising focus on the development of extensive pipeline drugs and therapeutic antibodies may further surge the global market demand. However, the cost and time-intensive antibody development process impede the growth of the market over the forecast period of 2021-2027. Also, the rising demand for personalized medicine in protein therapeutics and high growth opportunities in developing countries is anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global Custom Antibody market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing demand for high-quality research tools for data reproducibility and growing investments in the development of structure-based drug designs. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2021-2027. Factors such as the growing focus on developing antibody-based therapeutics, as well as a rising emphasis in the fields of genomics and proteomics, would create lucrative growth prospects for the Custom Antibody market across the Asia-Pacific region.
Major market players included in this report are:
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Merck Group
Cell Signaling Technology, Inc.
BioLegend
Rockland Immunochemicals
Raybiotech, Inc.
Abbiotec, Inc.
Sino Biological, Inc.
Boster Biological Technology
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Service offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Service:
Antibody Development
Antibody Production & Purification
Antibody Fragmentation & Labeling
By Type:
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibodies
Other Custom Antibodies
By Source:
Mice
Rabbits
Other Sources
By Research Area:
Oncology
Infectious Diseases
Neurobiology
Stem Cells
Immunology
Cardiovascular Disease
Other Research Areas
By End User:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027
Target Audience of the Global Custom Antibody Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
- 1.2.1. Global Custom Antibody Market, by Region, 2020-2028 (USD Million)
- 1.2.2. Global Custom Antibody Market, by Service, 2020-2028 (USD Million)
- 1.2.3. Global Custom Antibody Market, by Type, 2020-2028 (USD Million)
- 1.2.4. Global Custom Antibody Market, by Source, 2020-2028 (USD Million)
- 1.2.5. Global Custom Antibody Market, by Research Area, 2020-2028 (USD Million)
- 1.2.6. Global Custom Antibody Market, by End User, 2020-2028 (USD Million)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Custom Antibody Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Custom Antibody Market Dynamics
- 3.1. Custom Antibody Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Increasing industry-academia collaborations
- 3.1.1.2. Growing focus on therapeutic antibodies and extensive pipeline drugs
- 3.1.2. Market Challenges
- 3.1.2.1. Cost- and time-intensive antibody development process
- 3.1.3. Market Opportunities
- 3.1.3.1. Rising demand for personalized medicine in protein therapeutics
- 3.1.3.2. High growth opportunities in developing countries
Chapter 4. Global Custom Antibody Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Custom Antibody Market, by Service
- 6.1. Market Snapshot
- 6.2. Global Custom Antibody Market by Service, Performance - Potential Analysis
- 6.3. Global Custom Antibody Market Estimates & Forecasts by Service 2019-2028 (USD Million)
- 6.4. Custom Antibody Market, Sub Segment Analysis
- 6.4.1. Antibody Development
- 6.4.2. Antibody Production & Purification
- 6.4.3. Antibody Fragmentation & Labelling
Chapter 7. Global Custom Antibody Market, by Type
- 7.1. Market Snapshot
- 7.2. Global Custom Antibody Market by Type, Performance - Potential Analysis
- 7.3. Global Custom Antibody Market Estimates & Forecasts by Type 2019-2028 (USD Million)
- 7.4. Custom Antibody Market, Sub Segment Analysis
- 7.4.1. Monoclonal Antibodies
- 7.4.2. Polyclonal Antibodies
- 7.4.3. Recombinant Antibodies
- 7.4.4. Other Custom Antibodies
Chapter 8. Global Custom Antibody Market, by Source
- 8.1. Market Snapshot
- 8.2. Global Custom Antibody Market by Source, Performance - Potential Analysis
- 8.3. Global Custom Antibody Market Estimates & Forecasts by Source 2019-2028 (USD Million)
- 8.4. Custom Antibody Market, Sub Segment Analysis
- 8.4.1. Mice
- 8.4.2. Rabbits
- 8.4.3. Other Sources
Chapter 9. Global Custom Antibody Market, by Research Area
- 9.1. Market Snapshot
- 9.2. Global Custom Antibody Market by Research Area, Performance - Potential Analysis
- 9.3. Global Custom Antibody Market Estimates & Forecasts by Research Area 2019-2028 (USD Million)
- 9.4. Custom Antibody Market, Sub Segment Analysis
- 9.4.1. Oncology
- 9.4.2. Infectious Diseases
- 9.4.3. Neurobiology
- 9.4.4. Stem Cells
- 9.4.5. Immunology
- 9.4.6. Cardiovascular Disease
- 9.4.7. Other Research Areas
Chapter 10. Global Custom Antibody Market, by End User
- 10.1. Market Snapshot
- 10.2. Global Custom Antibody Market by End User, Performance - Potential Analysis
- 10.3. Global Custom Antibody Market Estimates & Forecasts by End User 2019-2028 (USD Million)
- 10.4. Custom Antibody Market, Sub Segment Analysis
- 10.4.1. Pharmaceutical & Biotechnology Companies
- 10.4.2. Academic & Research Institutes
- 10.4.3. Contract Research Organizations
Chapter 11. Global Custom Antibody Market, Regional Analysis
- 11.1. Custom Antibody Market, Regional Market Snapshot
- 11.2. North America Custom Antibody Market
- 11.2.1. U.S. Custom Antibody Market
- 11.2.1.1. Service estimates & forecasts, 2019-2028
- 11.2.1.2. Type estimates & forecasts, 2019-2028
- 11.2.1.3. Source estimates & forecasts, 2019-2028
- 11.2.1.4. Research Area estimates & forecasts, 2019-2028
- 11.2.1.5. End User estimates & forecasts, 2019-2028
- 11.2.2. Canada Custom Antibody Market
- 11.3. Europe Custom Antibody Market Snapshot
- 11.3.1. U.K. Custom Antibody Market
- 11.3.2. Germany Custom Antibody Market
- 11.3.3. France Custom Antibody Market
- 11.3.4. Spain Custom Antibody Market
- 11.3.5. Italy Custom Antibody Market
- 11.3.6. Rest of Europe Custom Antibody Market
- 11.4. Asia-Pacific Custom Antibody Market Snapshot
- 11.4.1. China Custom Antibody Market
- 11.4.2. India Custom Antibody Market
- 11.4.3. Japan Custom Antibody Market
- 11.4.4. Australia Custom Antibody Market
- 11.4.5. South Korea Custom Antibody Market
- 11.4.6. Rest of Asia Pacific Custom Antibody Market
- 11.5. Latin America Custom Antibody Market Snapshot
- 11.5.1. Brazil Custom Antibody Market
- 11.5.2. Mexico Custom Antibody Market
- 11.6. Rest of The World Custom Antibody Market
Chapter 12. Competitive Intelligence
- 12.1. Top Market Strategies
- 12.2. Company Profiles
- 12.2.1. Thermo Fisher Scientific, Inc.
- 12.2.1.1. Key Information
- 12.2.1.2. Overview
- 12.2.1.3. Financial (Subject to Data Availability)
- 12.2.1.4. Service Summary
- 12.2.1.5. Recent Developments
- 12.2.2. Bio-Rad Laboratories, Inc.
- 12.2.3. Merck Group
- 12.2.4. Cell Signaling Technology, Inc.
- 12.2.5. BioLegend
- 12.2.6. Rockland Immunochemicals
- 12.2.7. Raybiotech, Inc.
- 12.2.8. Abbiotec, Inc.
- 12.2.9. Sino Biological, Inc.
- 12.2.10. Boster Biological Technology
Chapter 13. Research Process
- 13.1. Research Process
- 13.1.1. Data Mining
- 13.1.2. Analysis
- 13.1.3. Market Estimation
- 13.1.4. Validation
- 13.1.5. Publishing
- 13.2. Research Attributes
- 13.3. Research Assumption